Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Pelthos Therapeutics Inc. (PTHS) had Cash Flow from Financial Activities of $45.34M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$9.39M |
|
$-21.66M |
|
$1.67M |
|
$7.72M |
|
$21.39M |
|
$-12.00M |
|
$-16.58M |
|
$-28.59M |
|
$-28.30M |
|
$-21.66M |
|
$-21.66M |
|
$-21.66M |
|
$-21.34M |
|
$-12.00M |
|
$-10.79M |
|
1.88M |
|
1.88M |
|
$-9.16 |
|
$-9.16 |
|
| Balance Sheet Financials | |
$53.41M |
|
$9.59M |
|
$76.99M |
|
$130.40M |
|
$25.99M |
|
$31.44M |
|
$65.52M |
|
$91.52M |
|
$38.88M |
|
$-25.27M |
|
$38.88M |
|
3.23M |
|
| Cash Flow Statement Financials | |
$-22.59M |
|
$-5.24M |
|
|
Cash Flow from Financial Activities |
$45.34M |
$0.51M |
|
$18.02M |
|
$17.51M |
|
$5.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.05 |
|
-- |
|
-- |
|
0.45 |
|
0.81 |
|
82.19% |
|
-127.85% |
|
-127.85% |
|
-- |
|
-304.47% |
|
-230.74% |
|
$-22.69M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.07 |
|
1.06 |
|
84.91 |
|
-55.72% |
|
85.73% |
|
-16.61% |
|
-30.81% |
|
$12.02 |
|
$-12.07 |
|
$-12.01 |
|